Journal article
Proportion attributable to contextual effects in general medicine: a meta-epidemiological study based on Cochrane reviews
- Abstract:
- PurposeTo quantify the proportion of the overall clinical improvement produced by intra-articular mesenchymal stem cell (MSC) injections for knee osteoarthritis (KOA) that is attributable to contextual (placebo-related) effects.MethodsThis PRISMA-compliant systematic review and meta-analysis (PROSPERO CRD420251026818) searched five databases (CENTRAL, Embase, MEDLINE, Web of Science and Scopus) to 24 March 2025. Randomized controlled trials enrolling adults with KOA that compared MSC injections with inert placebo were included. Primary outcome was change in pain intensity (VAS or WOMAC-pain); physical function was analysed secondarily. Two reviewers independently extracted data and assessed risk of bias. The proportion of the treatment effect attributable to contextual factors (PCE) was calculated as described by Tsutsumi et al. Pain and function outcomes at 6 and 12 months were pooled with inverse-variance random-effects meta-analysis, and evidence certainty was appraised using GRADE.ResultsEight RCTs (467 patients) met the inclusion criteria. At 6 months, contextual factors accounted for approximately 63% of pain reduction and 61% of functional improvement, with low heterogeneity (I2 ≤ 8%). At 12 months, contextual factors explained ~50% of pain relief and ~66% of functional gains, again with very low heterogeneity (I2 = 0%). Certainty of evidence was rated low for both time-points (GRADE).ConclusionBased on low-certainty evidence, this meta-analysis suggests that in knee osteoarthritis the majority of symptomatic improvement following intra-articular MSC injections is attributable to contextual (placebo) effects, whereas the MSCs themselves confer only a modest incremental benefit.Systematic review registrationCRD4-2025-1636181, https://www.crd.york.ac.uk/PROSPERO/view/CRD420251026818
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 634.1KB, Terms of use)
-
- Publisher copy:
- 10.1136/bmjebm-2021-111861
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- BMJ Evidence-Based Medicine More from this journal
- Volume:
- 28
- Issue:
- 1
- Pages:
- 40-47
- Publication date:
- 2022-07-19
- Acceptance date:
- 2022-06-24
- DOI:
- EISSN:
-
2515-4478
- ISSN:
-
2515-446X
- Language:
-
English
- Keywords:
- Pubs id:
-
1270356
- Local pid:
-
pubs:1270356
- Source identifiers:
-
W4285794253
- Deposit date:
-
2026-04-27
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2022
If you are the owner of this record, you can report an update to it here: Report update to this record